Information  X 
Enter a valid email address

Lifeline Scientific (LSI)

  Print      Mail a friend

Friday 28 October, 2011

Lifeline Scientific

Holding(s) in Company

RNS Number : 0397R
Lifeline Scientific, Inc
28 October 2011
 

Lifeline Scientific, Inc.

("Lifeline" or "the Company")

 

Holding in Company

 




TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi



1. Identity of the issuer or the underlying issuer
of existing shares to which voting rights are
attached:
ii

Lifeline Scientific, Inc.

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

X

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

-

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

-

An event changing the breakdown of voting rights

-

Other (please specify):


-

3. Full name of person(s) subject to the
notification obligation:
iii

Société Fédérale de Participations et d'Investissement

4. Full name of shareholder(s)
 (if different from 3.):iv

Dexia Bank Belgium SA

5. Date of the transaction and date on
which the threshold is crossed or
reached:
v

20 October 2011

6. Date on which issuer notified:

26 October 2011

7. Threshold(s) that is/are crossed or
reached:
vi, vii

3% and 4%



 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type of
shares


if possible using
the ISIN CODE

Situation previous
to the triggering
transaction

Resulting situation after the triggering transaction

Number
of
Shares

Number
of
Voting
Rights

Number
of shares

Number of voting
rights

% of  voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

USU529641008

0

0

790,116

790,116

0

4.075%

0%



B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial
instrument

Expiration
date
xiii

Exercise/
Conversion Period
xiv

Number of voting
rights that may be
acquired if the
instrument is
exercised/ converted.

% of voting
rights

-






C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financial
instrument

Exercise price

Expiration date xvii

Exercise/
Conversion period
xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

-




 

 

Nominal

Delta




Total (A+B+C)

Number of voting rights

Percentage of voting rights

790,116

4.075%



 

9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable:
xxi

 

On October 20, 2011, the Société Fédérale de Participations et d'Investissement, acting in its own name but on behalf of the Belgian State, acquired Dexia Bank Belgium from Dexia SA.  Dexia Bank Belgium owns 4.075% of shares in Lifline Scientific Inc.


Proxy Voting:

10. Name of the proxy holder:

-

11. Number of voting rights proxy holder will cease
to hold:


12. Date on which proxy holder will cease to hold
voting rights:




13. Additional information:



14. Contact name:

Mr. Koenraad Van Loo

Managing Director

15. Contact telephone number:

+32 2 548 52 03

 

Enquiries:

 

Lifeline Scientific, Inc.

+ 1 847 294 0300

David Kravitz, CEO


Seymour Pierce

(Nominated Adviser and Broker)

+44 (0)20 7107 8000

Sarah Jacobs (Corporate Finance)


David Banks (Corporate Broking)


Financial Dynamics

+44 (0)20 7831 3113

Ben Brewerton / John Dineen


 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLMPBLTMBBTMRB